Lonza (LONN)

Sector:

Medicine and Biotech Research

Index:

Swiss Market Index

Sf 35.13
   
  • 52 Week High: Sf73.70
  • 52 Week Low: Sf34.42
  • Currency: Swiss Francs
  • Shares Issued: 52.92m
  • Market Cap: Sf1,859.08m

Lonza Overview

Lonza Group is a Swiss chemicals and biotechnology company. The group provides a number of products and services to the pharmaceutical and life science industries.

3 Month Chart (25-05-2012)

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 6.1%
Div Cover 2.6
Op Mrgn 14.0%
ROCE 10.5%
Latest F'cast
P/E 6.3
PEG 0.1
Pr/Revenue 0.7
Pr/Book 0.8
Latest F'cast
Revenue -0.4%
PBT 77.4%
EPS 74.0%
DPS 22.9%

Lonza Fundamentals

Year Ending Revenue (Sfm) Pre-tax (Sfm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-06 2,285.00 251.00 4.69Sf 22.5 1.2 +18% 1.50 1.4%
31-Dec-07 2,870.00 361.00 6.33Sf n/a n/a +35% 1.75 0.0%
31-Dec-08 2,937.00 475.00 8.81Sf 11.1 0.3 +39% 1.75 1.8%
31-Dec-09 2,690.00 186.00 3.19Sf 22.9 n/a -64% 1.75 2.4%
31-Dec-10 2,680.00 330.00 5.55Sf 13.5 0.2 +74% 2.15 2.9%

Lonza Forecasts

Year Ending Revenue (Sfm) Pre-tax (Sfm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-11 2,692.00 194.46 3.40Sf 10.3 0.0 +6,035% 2.15Sf 5.7%
31-Dec-12 3,787.61 236.08 4.08Sf 8.6 0.4 +20% 1.98Sf 5.3%
31-Dec-13 3,922.78 299.53 4.74Sf 7.4 0.5 +16% 2.04Sf 5.4%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Lonza Market Data

Currency Swiss Francs
% Change 0.86 %
52 Week High Sf73.70
52 Week Low Sf34.42
Shares Issued 52.92m
Market Cap Sf1,859.08m

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 11
Sell 1
Strong Sell 2
Total 17
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page